Leuprolide Unknown Status Phase 3 Trials for Prostate Cancer Treatment

IndicationsStatusPurposePhase
Unknown StatusTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT00175383Long Acting LHRH Versus Short Acting LHRH in the Treatment of Prostate Cancer